Phase II clinical trial results presented at the American Academy of Dermatology 2019 Annual Meeting

Dr. Stacy R. Smith presented an abstract entitled – “Successful Treatment of Common Warts with Candida Extract – a Phase II study” at the Annual Meeting of the American Academy of Dermatology in Washington DC. Read More –

Candida albicans Skin Test Antigen for Cellular Hypersensitivity has not been proven safe and effective for use in warts.  Nielsen BioSciences intends to pursue FDA approval in the near future.